Dimitrios C Ziogas Selected Research

Dimitrios C Ziogas Research Topics

Disease

16	Neoplasms (Cancer) 02/2024 - 12/2018
13	Melanoma (Melanoma, Malignant) 05/2023 - 01/2019
8	Multiple Myeloma 12/2019 - 01/2017
6	Infections 04/2023 - 01/2013
5	Immunoglobulin Light-chain Amyloidosis 10/2019 - 01/2017
4	Colitis 05/2021 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 08/2009
3	Disease Progression 05/2021 - 01/2017
3	Amyloidosis 10/2019 - 01/2018
3	Inflammation (Inflammations) 05/2014 - 01/2012
2	Microsatellite Instability 01/2024 - 05/2022
2	Rheumatoid Arthritis 12/2021 - 06/2012
2	Hepatitis 11/2020 - 10/2020
2	Residual Neoplasm 12/2019 - 10/2019
1	Diabetes Mellitus 02/2024
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2024
1	Cytomegalovirus Infections (Inclusion Disease) 04/2023
1	Gastritis 04/2023
1	Genomic Instability 02/2023
1	Skin Neoplasms (Skin Cancer) 06/2022
1	Paraganglioma (Paragangliomas) 01/2022
1	Pheochromocytoma 01/2022
1	Nausea 05/2021
1	Crohn Disease (Crohn's Disease) 05/2021
1	Diarrhea 05/2021
1	Fever (Fevers) 05/2021
1	Granuloma 05/2021
1	Lymphadenitis (Adenitis) 01/2021
1	Nephritis 01/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Myasthenia Gravis 01/2021
1	Autoimmune Diseases of the Nervous System 01/2020
1	Hypercalcemia (Milk Alkali Syndrome) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Exanthema (Rash) 10/2019
1	Constipation 10/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2019
1	Familial Amyloidosis (Hereditary Amyloidosis) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2019
6	IpilimumabIBA 05/2023 - 01/2020
6	Lenalidomide (CC 5013)FDA Link 12/2019 - 07/2017
5	NivolumabIBA 05/2023 - 04/2018
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021 - 01/2020
5	melanin-concentrating hormone (melanin concentrating hormone)IBA 05/2014 - 01/2012
4	AutoantibodiesIBA 02/2024 - 06/2017
4	pembrolizumabIBA 04/2023 - 04/2018
4	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019 - 12/2017
4	Bortezomib (Velcade)FDA Link 10/2019 - 01/2017
3	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
2	Monoclonal AntibodiesIBA 01/2024 - 01/2018
2	SteroidsIBA 12/2021 - 11/2020
2	atezolizumabIBA 01/2021 - 04/2018
2	Antiviral Agents (Antivirals)IBA 10/2020 - 06/2017
2	Immunomodulating AgentsIBA 12/2019 - 01/2018
2	Dihydrotachysterol (AT 10)IBA 12/2019 - 10/2019
2	EnzymesIBA 01/2019 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2018 - 04/2018
2	Dextrans (Dextran)FDA Link 05/2013 - 01/2012
1	cyclopropapyrroloindoleIBA 02/2024
1	Bispecific AntibodiesIBA 01/2024
1	Immune Checkpoint ProteinsIBA 05/2023
1	relatlimabIBA 05/2023
1	Tryptophan (L-Tryptophan)FDA Link 02/2023
1	Adenosine (Adenocard)FDA LinkGeneric 02/2023
1	talimogene laherparepvecIBA 06/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	VaccinesIBA 12/2021
1	dabrafenibIBA 01/2021
1	trametinibIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2020
1	Prednisolone (Predate)FDA LinkGeneric 11/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	pomalidomideIBA 12/2019
1	Nerve Growth Factor (NGF)IBA 12/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019
1	Drug CombinationsIBA 10/2019
1	Melphalan (Alkeran)FDA LinkGeneric 10/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	GelsolinIBA 01/2019
1	Prealbumin (Transthyretin)IBA 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2019
1	Cystatin CIBA 01/2019
1	Muramidase (Lysozyme)IBA 01/2019

Therapy/Procedure

18	Therapeutics 01/2024 - 01/2017
12	Immunotherapy 01/2024 - 04/2018
6	Drug Therapy (Chemotherapy) 05/2022 - 08/2009
2	Aftercare (After-Treatment) 11/2020 - 01/2017
1	Radioimmunotherapy 01/2024
1	Intralesional Infusions 06/2022
1	Drug Tapering 10/2019